CXCL8 and cancer: Interestingly, as seen with other senescence markers, the increased plasmatic levels of IL-8 seen in aMCI patients were significantly reduced in the Ca + aMCI group, attaining values like those of controls and cancer survivor groups, again favoring the suggestion that having had cancer leaves a trail.